Table 2.
Unweighted 30-days, 12-month, and lifetime prevalencea of mental disorders among female students.
| 30 days prevalence |
12-month prevalence |
Lifetime prevalence |
||||
|---|---|---|---|---|---|---|
| % (95% CI) | Frequency (valid observations) | % (95% CI) | Frequency (valid observations) | % (95% CI) | Frequency (valid observations) | |
| Mood disorders | ||||||
| Major depressive episode | 17.1% (16.2%, 17.9%) | 1250 (7329) | 35.3% (34.2%, 36.4%) | 2572 (7289) | 46.0% (44.9%, 47.2%) | 3359 (7297) |
| Anxiety disorders | ||||||
| Any anxiety disorder | 29.9% (28.8%, 31.0%) | 2092 (6999) | 40.7% (39.5%, 41.9%) | 2790 (6859) | 48.4% (47.2%, 49.6%) | 3333 (6886) |
| Generalized anxiety disorder | 16.0% (15.2%, 16.9%) | 1157 (7221) | 23.8% (22.8%, 24.8%) | 1625 (6837) | 29.0% (27.9%, 30.1%) | 1982 (6837) |
| Agoraphobia | 2.0% (1.65%, 2.32%) | 138 (7046) | 2.9% (2.56%, 3.37%) | 207 (7046) | 3.7% (3.32%, 4.22%) | 264 (7046) |
| Panic disorder | 7.4% (6.76%, 7.98%) | 529 (7197) | 14.4% (13.6%, 15.2%) | 1034 (7197) | 19.4% (18.5%, 20.3%) | 1396 (7197) |
| Social anxiety disorder | 10.0% (9.27%, 10.7%) | 697 (6998) | 13.6% (12.8%, 14.4%) | 949 (6998) | 16.2% (15.4%, 17.1%) | 1136 (6998) |
| Specific phobia | 9.6% (8.96%, 10.4%) | 679 (7047) | 11.9% (11.1%, 12.7%) | 838 (7047) | 14.1% (13.3%, 14.9%) | 994 (7047) |
| Substance-use disorder | ||||||
| Any substance-use disorder | 6.0% (5.41%, 6.55%) | 406 (6815) | 10.6% (9.90%, 11.4%) | 724 (6819) | 17.7% (16.8%, 18.6%) | 1208 (6830) |
| Alcohol use disorder | 5.6% (5.05%, 6.14%) | 387 (6948) | 7.7% (7.09%, 8.36%) | 535 (6948) | 16.1% (15.3%, 17.0%) | 1119 (6948) |
| Drug use disorder | 0.5% (0.39%, 0.76%) | 37 (6817) | 3.7% (3.27%, 4.18%) | 252 (6817) | 3.7% (3.27%, 4.18%) | 252 (6817) |
| Any disorder | 39.7% (38.6%, 40.9%) | 2737 (6886) | 57.3% (56.1%, 58.4%) | 3977 (6945) | 67.3% (66.1%, 68.3%) | 4730 (7033) |
a
Prevalences are based on the number of female students with valid responses on the diagnostic section of interest.